MJardin Group, Inc. ( MJARF) - Key Metrics
MJARF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2021Q3 | $0.01 | -$0.22 | -$0.02 | -$0.02 |
| 2021Q2 | $0.01 | -$0.10 | $0.04 | $0.03 |
| 2021Q1 | $0.01 | -$0.03 | -$0.01 | -$0.01 |
| 2020Q4 | $0.03 | -$0.23 | -$0.11 | -$0.11 |
| 2020Q3 | $0.05 | $0.08 | -$0.02 | -$0.05 |
MJARF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2021Q3 | 0% | -0.02 |
| 2021Q2 | 0% | -0.14 |
| 2021Q1 | 0% | -0.76 |
| 2020Q4 | 0% | -0.05 |
| 2020Q3 | 0% | 0.17 |
MJARF
Price: $0
52 week price:
Earnings Per Share: -0.45 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 9014